Hendrik Schulze‐Koops
LMU Klinikum(DE)München Klinik(DE)Ludwig-Maximilians-Universität München(DE)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Autoimmune and Inflammatory Disorders Research, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology
Most-Cited Works
- → EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update(2022)1,636 cited
- → Trial of Tocilizumab in Giant-Cell Arteritis(2017)1,333 cited
- → Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis(2012)1,013 cited
- → Role of Th17 cells in human autoimmune arthritis(2010)446 cited
- → Treg cells suppress osteoclast formation: A new link between the immune system and bone(2007)366 cited
- → Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial(2013)339 cited